Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Postmenopausal hormone replacement therapy and colorectal cancer risk by molecular subtypes and pathways.

International journal of cancer - 15 Aug 2020

Amitay Efrat L, Carr Prudence R, Jansen Lina, Alwers Elizabeth, Roth Wilfried, Herpel Esther, Kloor Matthias, Bläker Hendrik, Chang-Claude Jenny, Brenner Hermann, Hoffmeister Michael

Abstract excerpt

Postmenopausal hormone replacement therapy (HRT) was found to be associated with lower risk of colorectal cancer (CRC). However, little is known regarding associations with molecular subtypes of CRC. The current study includes female participants of a large German population-based case-control study (922 CRC cases and 1,183 controls). Tumor tissue samples were analyzed for microsatellite instability (MSI), CpG...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CpG Islands
Share to Estrogen Replacement Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Germany

Share to Microsatellite Instability

Share to Multivariate Analysis

Share to Postmenopause

Share to Proto-Oncogene Proteins B-raf

Share to Proto-Oncogene Proteins p21(ras)

Source

Identifiers

PMID: 31943160
DOI: 10.1002/ijc.32868

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Postmenopausal hormone replacement therapy and colorectal cancer risk by molecular subtypes and pathways.PMID 31943160Read ↗

Postmenopausal hormone therapy and colorectal cancer risk by molecularly defined subtypes among older women.Semantic proximity Read ↗

Associations of hormone replacement therapy and oral contraceptives with risk of colorectal cancer defined by clinicopathological factors, beta-catenin alterations, expression of cyclin D1, p53, and microsatellite-instability.Semantic proximity Read ↗

Genetic risk impacts the association of menopausal hormone therapy with colorectal cancer risk.Semantic proximity Read ↗

Association Between Smoking and Molecular Subtypes of Colorectal Cancer.Semantic proximity Read ↗

Postmenopausal hormone therapy and colorectal cancer risk in relation to somatic KRAS mutation status among older women.Semantic proximity Read ↗

Sex Steroid Receptors in Colorectal Cancer: Implications for Tumor Progression, Therapeutic Opportunities, and Sex-Specific OutcomesSemantic proximity Read ↗

Risk Factors and Incidence of Colorectal Cancer According to Major Molecular Subtypes.Semantic proximity Read ↗

Colonoscopy and Reduction of Colorectal Cancer Risk by Molecular Tumor Subtypes: A Population-Based Case-Control Study.Semantic proximity Read ↗

Molecular Subtypes of Colorectal Cancer and Their Clinicopathologic Features, With an Emphasis on the Serrated Neoplasia Pathway.Semantic proximity Read ↗

Colonoscopy and reduction of colorectal cancer risk by molecular tumor subtypes: a population-based case-control studySemantic proximity Read ↗

Smoking, alcohol consumption and colorectal cancer risk by molecular pathological subtypes and pathwaysSemantic proximity Read ↗

Estrogen and colon cancer:current issuesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.